PROVIDER PROFILE · NPI 1528175205

David LawsonM.D.

PRACTICEEMORY HEALTHCARESee all providers at this practice →

Hematology-OncologyAtlanta, GAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$8K

Peer benchmark

Total Medicare services vs. 236 Hematology-Oncology providers in GA — bottom quintile (cohort median 1,046).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$127

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Alprazolam14 claims

Oxycodone Hcl13 claims

QUALITY · MIPS · 2024

Final MIPS score

94.5

Quality

80.6

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.82%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where David Lawson's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
CRAWFORD LONG HOSPITAL	83	630
John Roback Pathology · Atlanta, GA	82	865
Brent Little Diagnostic Radiology · Jacksonville, FL	17	50
Eugene Berkowitz Diagnostic Radiology · Atlanta, GA	14	38
Bassel El-Rayes Medical Oncology · Detroit, MI	12	67
Hillary Brown-Adderely Nurse Practitioner · Miami, FL	11	25
Deborah Baumgarten Diagnostic Radiology · Jacksonville, FL	11	45

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history